Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31800 total
Iovance Biotherapeutics is pulling back from its September highs, down 10% on the week to $12.96, as the slow-motion short unwind continues and the Street reassesses what the commercial ramp is worth at this…
FITB has stabilised at $51.00 this week, but the calm on the surface masks a more interesting set of cross-currents heading into Q3 results on October 19. A note published earlier today covered the analyst…
Standard Nuclear enters the week having just posted its biggest seven-day gain of the year, up 26% to $15.19, while the borrow market and a fresh analyst initiation pull in opposite directions. The clearest driver of…
FDXF arrives at its October 9 debut earnings test with analysts still broadly bullish but cutting targets quickly, and a month-long stock slide that has widened the gap between the current price and where the Street…
XE heads into the final stretch before its November 13 earnings with a week of genuine price recovery sitting on top of a deeply contested investment case. The stock gained 8% over the past week to close at $15.45, a…
BRAI enters the new week with a peculiar disconnect: short sellers are quietly covering, yet borrowing the stock remains eye-wateringly expensive, a combination that makes the lending market worth watching closely. The…
LIFE enters the final stretch before its November 3 earnings with the Street divided, borrow conditions loose, and short sellers who doubled positions in a month now quietly trimming. The most important development…
WOLF heads into its October 27 earnings print carrying one of the most extreme short positioning setups in the US market, while the stock has simultaneously rallied 13% on the week. The lending market tells the story…
ANDG heads into the final stretch before November earnings with a notable tension: short sellers have been steadily rebuilding positions over the past month while analysts have been raising targets and the stock…
NP closed at $27.19 on Tuesday, down nearly 2% on the week and 18% over the past month, yet its next earnings print is just 14 days away. The most striking signal this week is not in the short book. It is in Wikipedia…
The shorts that retreated from the XRP Bitwise XRP ETF just days ago have returned with force, pushing the fund back into the same territory that defined last month's squeeze episode. The turnaround in short interest…
Hinge Health enters the first week of October with a shift in the short-selling trend that reverses the retreat documented just days ago, while options traders remain positioned firmly on the bullish side and the…
CoreWeave enters the week after its next earnings date with short interest still entrenched at elevated levels, a stock that has rebounded 7% in a week, and a Street that has turned markedly more constructive, creating…
SNDK heads into its October 29 earnings print with the stock down 4% on the week, short sellers showing tentative signs of rebuilding after a month of covering, and analysts still clustered well above the current…
FNGU, the MicroSectors FANG+ 3x Leveraged ETN, has climbed more than 10% over the past month and is up nearly 6% on the week, yet the lending market is telling a story that runs against the rally's momentum. The most…
BULL heads into its October 30 earnings date with a stock down 25% over the past month, short interest at its highest level in six weeks, and the CEO's shareholding structure shifting in a way that warrants a closer…
BALY enters the second week of October with a borrow market that has gone from tight to extreme, while the stock itself has quietly more than doubled from its August lows, creating a charged standoff between shorts…
BLK enters its October 14 earnings report at $1,079.42, down 3.8% over the past month but clawing back 1.1% this week, with the Street actively repricing targets in both directions ahead of the print. The most active…
BKV Corporation enters the final stretch before its November 6 earnings report with short interest close to doubling over the past month, even as the analyst consensus points to more than 50% upside from current…
BTC, the Grayscale Bitcoin Mini Trust, has recovered from last week's pullback and the options positioning that briefly hit a twelve-month extreme has since normalised, leaving the trust in a quieter but still…
